2021 Investor Day

Sleep and Respiratory Care snapshot $2.8B FY 2021 revenue Europe, Asia, and Other 140+ Countries 16.5M+ Patients in AirView FY 2021 SRC revenue by region 40% O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 9B + Nights of data FY 2021 SRC revenue by product 43% U.S., Canada, Masks & and Latin Other America 60% Devices 57% 28

View entire presentation